Find your next paid study

Medical University of South CarolinaNCT06922617

Actual pay is set by the research site.

Phase 2

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors t…

Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more

Phase 4

A Single-arm Open-label Safety Study of SMOFlipid to Evaluate the Risk of Developing Essential Fatty Acid Deficiency (EFAD) and/or Parenteral Nutrition-associated Cholestasis (PNAC) in Pediatric Patients 1 Month to 17 Years of Age and in Adult Patients, Who Are Anticipated to Need 8 Weeks or Longer of Parenteral Nutrition Treatment

Evaluate the risk of developing EFAD and/or PNAC in adult and pediatric patients 1 month of age and older, who are anticipated to need 8 weeks or longer of par…

Malnutrition, ChildMalnutritionEssential Fatty Acid Deficiency (EFAD)+1 more

Fresenius KabiNCT06049680

~$25 – $1,500

Actual pay is set by the research site.

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Impr…

Intubation Complication

Children's Hospital of PhiladelphiaNCT06085326

Actual pay is set by the research site.

Infant DevelopmentLanguage DevelopmentPrematurity+1 more

The Impact of Music Medicine on Preterm Brain Development and Behavior - A Two-Center Randomized Controlled Trial "The Lullaby Study"

The investigators are conducting a two-site randomized control trial with the aim of defining the impact of music (M) without or with parent voice (MPV) on ver…

Brigham and Women's HospitalNCT06536296

Actual pay is set by the research site.

Phase 1

Phase 1/2 Study of Intravesical MK-3120 in BCG-Naïve or BCG-Exposed High-Risk Non-muscle Invasive Bladder Cancer

Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of t…

Bladder CancerUrinary Bladder Neoplasms

Merck Sharp & Dohme LLCNCT07222488

~$150 – $4,200

Actual pay is set by the research site.

A Pilot Companion Cancer Cohort Study to the Wake Forest COSMIC Study (WF-2304) in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal

This study is being done because there is a significant lack of data on the use of cannabis amongst cancer patients. The investigators believe that the collect…

Cancer

~$10 – $1,125

Actual pay is set by the research site.

Scot RemickNCT07089225

Phase 2

A Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab Compared to Placebo in Adult Participants With Graves' Disease

In this study, researchers will learn more about the use of felzartamab in participants with Graves' Disease, also known as GD. GD is an autoimmune disease, wh…

Graves' Disease

~$75 – $3,000

Actual pay is set by the research site.

BiogenNCT07722546

Degenerative Lumbar Spine DiseasesLumbar Degenerative Disc DiseaseLumbar Spinal Stenosis+1 more

A Prospective, Randomized Controlled Trial of Kore Fiber® Versus Autograft in Posterolateral Lumbar Fusion (PLF)

This is a prospective, randomized controlled trial evaluating Kore Fiber® versus autograft in adults undergoing posterolateral lumbar fusion (PLF). Participant…

Kolosis Bio, LLCNCT07868510

~$10 – $1,050

Actual pay is set by the research site.

Pediatric CancerAdolescent and Young Adult Cancer

Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a mul…

Connecticut Children's Medical CenterNCT06982066

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of the BCL-2 Inhibitor Surzetoclax (ABBV-453) Given as Monotherapy or in Combination With Antimyeloma Regimens in Subjects With Multiple Myeloma

Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess th…

Multiple Myeloma

~$150 – $4,500

Actual pay is set by the research site.

AbbVieNCT06953960

Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes

The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected f…

Breast Cancer